StockData
Cue Biopharma, Inc. logo

Cue Biopharma, Inc. (CUE) stock

CUENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/30
$2.83−11.27 (-79.93%)

Close on Nov 17, 2026Market cap $20.56MP/E –Yield –

Cue Biopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cue Biopharma's market cap was $97.58M on Nov 11, 2026, against $49.01M a year earlier. Over the last 5 years it ranged from $22.22M to $354.74M, with a median of $91.87M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$97.58M+310.7%
2025Dec 31, 2025$23.76M-63.8%
2024Dec 31, 2024$65.63M-44.9%
2023Dec 29, 2023$119.14M+18.1%
2022Dec 30, 2022$100.86M-71.6%
2021Dec 31, 2021$354.74M-6.3%
2020Dec 31, 2020$378.48M+3.8%
2019Dec 31, 2019$364.68M+285.4%
2018Dec 31, 2018$94.64M–

More Cue Biopharma figures

See a number that looks wrong?